Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VIRGINIA E KIMONIS

Allopathic & Osteopathic Physicians Medical Genetics Clinical Genetics (M.D.)

NPI
1912964925
CMS profile
559848
Location
ORANGE, CA

General Payments · PY2018–2024

$73,475.29

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$13,872.31

9 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $13,823.94 7
Takeda Pharmaceuticals U.S.A., Inc. $25.43 1
ARGENX US, INC. $22.94 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,130.97 23
PY2019 $14,002.59 18
PY2020 $11,339.17 11
PY2021 $3,248.00 2
PY2022 $13,941.72 11
PY2023 $7,940.53 12
PY2024 $13,872.31 9

Payment records · PY2024 (9)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ARGENX US, INC. $22.94 10/27/2024 Food and Beverage Undisputed 01/23/2026 1142121475 CMS
GENZYME CORPORATION $4,096.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1139651243 CMS
GENZYME CORPORATION $125.01 07/29/2024 Food and Beverage Undisputed 01/23/2026 1139651295 CMS
GENZYME CORPORATION $20.06 11/18/2024 Food and Beverage Undisputed 01/23/2026 1139651303 CMS
GENZYME CORPORATION $79.18 11/18/2024 Food and Beverage Undisputed 01/23/2026 1139651319 CMS
GENZYME CORPORATION $8,596.00 11/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139651321 CMS
GENZYME CORPORATION $272.61 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1139651323 CMS
GENZYME CORPORATION $635.08 11/18/2024 Travel and Lodging Undisputed 01/23/2026 1139651325 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.43 09/13/2024 Food and Beverage Undisputed 01/23/2026 1137602752 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.